QA: Repare Therapeutics Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001808158_2022_Repare_Therapeutics_Inc.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAndComprehensiveIncomeLoss'}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001808158')"}

Graph

Absolute values for 0001808158, Repare Therapeutics Inc.

  xvar xval
0 AssetsCurrent 351,414,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,604,000
3 remainder_Assets 11,697,000
4 LiabilitiesCurrent 35,089,000
5 LiabilitiesNoncurrent 45,205,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 26,213,000
9 ResearchAndDevelopmentExpense 90,047,000
10 remainder_Expenses -1,678,000
11 remainder_Revenues 0
12 remainder_NetIncome 7,674,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 368,715,000
1 Liabilities 80,294,000
2 Expenses 114,582,000
3 Revenues 0
4 StockholdersEquity 288,421,000
5 NetIncome -106,908,000
6 ComprehensiveNetIncome -106,908,000
7 BaseVar 285,632,500
8 EconomicCapitalRatio 1.73

Edgar->Model Mapping

Feature Distribution

Change over Time